Literature DB >> 12438619

A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells.

Koh Fujinaga1, Dan Irwin, Ran Taube, Fan Zhang, Matthias Geyer, B Matija Peterlin.   

Abstract

The transcriptional elongation of human immunodeficiency virus type 1 (HIV-1) is mediated by the virally encoded transactivator Tat and its cellular cofactor, positive transcription elongation factor b (P-TEFb). The human cyclin T1 (hCycT1) subunit of P-TEFb forms a stable complex with Tat and the transactivation response element (TAR) RNA located at the 5' end of all viral transcripts. Previous studies have demonstrated that hCycT1 binds Tat in a Zn(2+)-dependent manner via the cysteine at position 261, which is a tyrosine in murine cyclin T1. In the present study, we mutated all other cysteines and histidines that could be involved in this Zn(2+)-dependent interaction. Because all of these mutant proteins except hCycT1(C261Y) activated viral transcription in murine cells, no other cysteine or histidine in hCycT1 is responsible for this interaction. Next, we fused the N-terminal 280 residues in hCycT1 with Tat. Not only the full-length chimera but also the mutant hCycT1 with an N-terminal deletion to position 249, which retained the Tat-TAR recognition motif, activated HIV-1 transcription in murine cells. This minimal hybrid mutant hCycT1-Tat protein bound TAR RNA as well as human and murine P-TEFb in vitro. We conclude that this minimal chimera not only reproduces the high-affinity binding among P-TEFb, Tat, and TAR but also will be invaluable for determining the three-dimensional structure of this RNA-protein complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438619      PMCID: PMC136680          DOI: 10.1128/jvi.76.24.12934-12939.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

Review 1.  Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.

Authors:  R Taube; K Fujinaga; J Wimmer; M Barboric; B M Peterlin
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

Review 2.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Functional differences between human and bovine immunodeficiency virus Tat transcription factors.

Authors:  H P Bogerd; H L Wiegand; P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Canine cyclin T1 rescues equine infectious anemia virus tat trans-activation in human cells.

Authors:  T R Albrecht; L H Lund; M A Garcia-Blanco
Journal:  Virology       Date:  2000-03-01       Impact factor: 3.616

5.  Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.

Authors:  R Taube; K Fujinaga; D Irwin; J Wimmer; M Geyer; B M Peterlin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.

Authors:  M E Garber; T P Mayall; E M Suess; J Meisenhelder; N E Thompson; K A Jones
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus.

Authors:  M Barboric; R Taube; N Nekrep; K Fujinaga; B M Peterlin
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.

Authors:  Y W Fong; Q Zhou
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation.

Authors:  Y T Kwak; D Ivanov; J Guo; E Nee; R B Gaynor
Journal:  J Mol Biol       Date:  1999-04-23       Impact factor: 5.469

10.  HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1.

Authors:  J Zhang; N Tamilarasu; S Hwang; M E Garber; I Huq; K A Jones; T M Rana
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

View more
  5 in total

1.  Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.

Authors:  Koh Fujinaga; Dan Irwin; Yehong Huang; Ran Taube; Takeshi Kurosu; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

2.  Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.

Authors:  Xin Lin; Dan Irwin; Satoshi Kanazawa; Laurence Huang; Joseph Romeo; T S Benedict Yen; B Matija Peterlin
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat.

Authors:  Kanchan Anand; Antje Schulte; Koh Fujinaga; Klaus Scheffzek; Matthias Geyer
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

4.  Molecular dynamics simulation and experimental verification of the interaction between cyclin T1 and HIV-1 Tat proteins.

Authors:  Kaori Asamitsu; Takatsugu Hirokawa; Yurina Hibi; Takashi Okamoto
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.

Authors:  Julie K Jadlowsky; Masanori Nojima; Antje Schulte; Matthias Geyer; Takashi Okamoto; Koh Fujinaga
Journal:  Retrovirology       Date:  2008-07-11       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.